FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegall, C. B.
Right arrow Articles by Pastan, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siegall, C. B.
Right arrow Articles by Pastan, I.

The FASEB Journal, Vol 5, 2843-2849, Copyright © 1991 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types

CB Siegall, S Epstein, E Speir, T Hla, R Forough, T Maciag, DJ Fitzgerald and I Pastan
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Chimeric proteins composed of acidic fibroblast growth factor (acidic FGF) and several forms of Pseudomonas exotoxin (PE) that cannot bind to the PE receptor have been produced in Escherichia coli by expressing chimeric genes in which DNA encoding acidic FGF is fused to various mutant forms of PE. These acidic FGF-PE fusion proteins were found to be cytotoxic to a variety of tumor cell lines including hepatocellular (PLC/PRF/5 and HEPG2), prostatic (LNCaP), colon (HT29), and breast (MCF- 7) carcinomas at concentrations of 1-70 ng/ml. The cytotoxic effects of acidic FGF-PE were FGF-receptor specific as demonstrated by competition with excess acidic FGF and by showing that acidic FGF-PE bound to the FGF receptor with the same affinity as acidic FGF. Furthermore, the cell-killing activity of acidic FGF-PE was toxin-mediated, as an acidic FGF-PE mutant, which does not possess ADP-ribosylation activity, failed to kill cells. These findings demonstrate that acidic FGF-PE is a potent cytotoxic molecule that can be targeted to FGF receptor-bearing cells. Because acidic FGF is a potent angiogenic molecule, cytotoxic acidic FGF-PE chimeras may have utility as anti-angiogenic agents. These molecules could be helpful in determining the functional role of FGF receptors in cellular processes.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. M. Dikov, M. B. Reich, L. Dworkin, J. W. Thomas, and G. G. Miller
A Functional Fibroblast Growth Factor-1 Immunoglobulin Fusion Protein
J. Biol. Chem., June 19, 1998; 273(25): 15811 - 15817.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. A. Sosnowski, A. M. Gonzalez, L. A. Chandler, Y. J. Buechler, G. F. Pierce, and A. Baird
Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)
J. Biol. Chem., December 27, 1996; 271(52): 33647 - 33653.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. Mesri, M Ono, R. Kreitman, M Klagsbrun, and I Pastan
The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans
J. Cell Sci., January 9, 1994; 107(9): 2599 - 2608.
[Abstract] [PDF]

Home page
 ScienceHome page
I Pastan and D FitzGerald
Recombinant toxins for cancer treatment
Science, November 22, 1991; 254(5035): 1173 - 1177.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The Federation of American Societies for Experimental Biology.